ロード中...
Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19
OBJECTIVES: Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19. This study is aimed to discover its molecular mechanism and provide potential drug targets. MATERIALS AND METHODS: An LQC target and...
保存先:
| 出版年: | Cell Prolif |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7705900/ https://ncbi.nlm.nih.gov/pubmed/33140889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12949 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|